397 related articles for article (PubMed ID: 22396159)
1. The structural biology of the FGF19 subfamily.
Beenken A; Mohammadi M
Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
[TBL] [Abstract][Full Text] [Related]
2. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
[TBL] [Abstract][Full Text] [Related]
4. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M
Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487
[TBL] [Abstract][Full Text] [Related]
5. The FGF metabolic axis.
Li X
Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
[TBL] [Abstract][Full Text] [Related]
6. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for FGF hormone signalling.
Chen L; Fu L; Sun J; Huang Z; Fang M; Zinkle A; Liu X; Lu J; Pan Z; Wang Y; Liang G; Li X; Chen G; Mohammadi M
Nature; 2023 Jun; 618(7966):862-870. PubMed ID: 37286607
[TBL] [Abstract][Full Text] [Related]
8. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
[TBL] [Abstract][Full Text] [Related]
9. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
[TBL] [Abstract][Full Text] [Related]
10. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
Itoh N
Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
[TBL] [Abstract][Full Text] [Related]
11. The Saga of Endocrine FGFs.
Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
13. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
14. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
[TBL] [Abstract][Full Text] [Related]
15. FGF23 signalling and physiology.
Ho BB; Bergwitz C
J Mol Endocrinol; 2021 Feb; 66(2):R23-R32. PubMed ID: 33338030
[TBL] [Abstract][Full Text] [Related]
16. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
[TBL] [Abstract][Full Text] [Related]
17. The Klotho proteins in health and disease.
Kuro-O M
Nat Rev Nephrol; 2019 Jan; 15(1):27-44. PubMed ID: 30455427
[TBL] [Abstract][Full Text] [Related]
18. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
[TBL] [Abstract][Full Text] [Related]
19. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
Kuro-O M
Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
[TBL] [Abstract][Full Text] [Related]
20. Co-receptor requirements for fibroblast growth factor-19 signaling.
Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
